Hillel Tobias
Expertise in
15
conditions

Dr. Hillel Tobias

Transplant Surgery | Gastroenterology | Internal Medicine
261 East 78th Street, 4th Floor, 
New York, NY 
On Staff At
60 Years of Experience
Expertise in
15
conditions
261 East 78th Street, 4th Floor, 
New York, NY 

Overview

Hillel Tobias is an Internal Medicine specialist and a Transplant Surgeon in New York, New York. Dr. Tobias has been practicing medicine for over 60 years is highly rated in 15 conditions, according to our data. His top areas of expertise are Hepatitis, Hepatitis C, Visceromegaly, Non-Alcoholic Fatty Liver Disease, and Liver Transplant.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Washington University

Residency

New York University Langone Medical Center

Specialties

Transplant Surgery
Gastroenterology
Internal Medicine

Licenses

Internal Medicine in NY

Board Certifications

American Board Of Internal Medicine
American Board Of Internal Medicine/Gastroenterology

Fellowships

Mount Sinai Hospital and Medical Center

Hospital Affiliations

Hofstra/Northwell School Of Medicine/Nursing
Lenox Hill Hospital
Transplant Institute

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northwell Health
  • INSURANCE PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Northwell Health Center for Liver Disease and Transplantation
261 East 78th Street, 4th Floor, New York, NY 10075

Additional Areas of Focus

Dr. Tobias has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: August 02, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

2 Total Publications

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2).
Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2).
Journal: Hepatology (Baltimore, Md.)
Published: September 04, 2015
Similar Doctors
Nikolaos Pyrsopoulos
Expertise in
23
conditions
Dr. Nikolaos Pyrsopoulos
Transplant Surgery | Gastroenterology
Expertise in
23
conditions
Dr. Nikolaos Pyrsopoulos
Transplant Surgery | Gastroenterology

Atlantic Medical Group Gastroenterology At Summit

33 Overlook Road, Suite 201, 
Summit, NJ 
 (21.2 miles away)
908-522-5040
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Nikolaos Pyrsopoulos is a Transplant Surgeon and a Gastroenterologist in Summit, New Jersey. Dr. Pyrsopoulos is highly rated in 23 conditions, according to our data. His top areas of expertise are Liver Failure, Hepatorenal Syndrome, Hepatitis, Liver Transplant, and Endoscopy. Dr. Pyrsopoulos is currently accepting new patients.

Gene Y. Im
Expertise in
21
conditions
Dr. Gene Y. Im
Gastroenterology | Transplant Surgery
Expertise in
21
conditions
Dr. Gene Y. Im
Gastroenterology | Transplant Surgery

CUIMC/Presbyterian Hospital And Vanderbilt Clinic

622 West 168th Street, 
New York, NY 
 (4.8 miles away)
212-305-0914
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dr. Gene Im is a transplant hepatologist and the Director of the Alcohol-associated Liver Disease Program at Columbia known as ADAPT (Advanced inter-Disciplinary Alcohol liver Program and Treatment), a patient-centered, integrated care and research program for patients with alcohol-associated liver disease (ALD). ADAPT is one of only a few integrated ALD clinics in the country.Dr. Im is an internationally recognized expert in ALD, including alcohol-associated hepatitis and liver transplantation based on his clinical focus and research achievements. He has co-authored several practice-changing articles, including the 2019 ALD Practice Guidance from AASLD, the 2024 MetALD Expert Position Statement, and the first experience of early liver transplantation for alcohol-associated hepatitis in North America.Currently, he is the Vice-Chair of the AASLD ALD Special Interest Group and serves on the Editorial Board for the journal Liver Transplantation. Dr. Im is also the founder of ALD-ALLY (Alcohol-associated Liver Disease patients deserve ALcohol LiteracY), an annual conference focused on actionable initiatives for advancing the science and care of patients with alcohol use disorder and ALD (www.ald-ally.com)Dr. Im is an Assistant Professor of Medicine in the Center for Liver Disease and Transplantation and Division of Digestive and Liver Diseases at Columbia University. Dr. Im is highly rated in 21 conditions, according to our data. His top areas of expertise are Hepatitis, Alcoholic Cirrhosis, Liver Failure, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Expertise in
26
conditions
Dr. Myron E. Schwartz
Transplant Surgery | General Surgery
Expertise in
26
conditions
Dr. Myron E. Schwartz
Transplant Surgery | General Surgery

Icahn School Of Medicine At Mount Sinai

13516 Roosevelt Ave, 
Flushing, NY 
 (6.6 miles away)
212-241-8035
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Myron Schwartz is a Transplant Surgeon and a General Surgeon in Flushing, New York. Dr. Schwartz is highly rated in 26 conditions, according to our data. His top areas of expertise are Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Fibrolamellar Carcinoma, Hepatectomy, and Liver Transplant.

Frequently Asked Questions about Dr. Hillel Tobias

How do I make an appointment with Dr. Hillel Tobias?

You can book an appointment with Dr. Hillel Tobias by calling their office at 646-374-0401. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Hillel Tobias a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hillel Tobias is classified as an Distinguished expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Hillel Tobias specialize in?

While Dr. Hillel Tobias is a Transplant Surgery, they have specific expertise in Hepatitis, Hepatitis C, and Visceromegaly. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Transplant Surgery.

Does Dr. Hillel Tobias participate in research or clinical trials?

Yes. Dr. Hillel Tobias has published 2 articles and abstracts on conditions like Hepatitis. You can view a list of Dr. Hillel Tobias's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Hillel Tobias accept my insurance?

Dr. Hillel Tobias accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 646-374-0401 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tobias's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 8 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile